Vaccine makers make new concessions in immunization drive
This article was originally published in Scrip
As international donors pledge to refill the coffers of the Gavi global vaccine alliance with $7.5bn for the next five years, manufacturers have committed to price cuts and extended special terms for access to their products.
You may also be interested in...
See how much the CEOs and R&D heads of the world’s biggest pharma companies get paid, and how those companies are performing.
Merck & Co is gradually catching up with Roche in PD-1/L1 first-line triple-negative breast cancer treatment, but its presentation at ASCO on Keynote-355 includes mixed PFS results. Overall survival data will be key to Keytruda’s competitiveness.
INFOGRAPHIC: A snapshot of the compensation packages granted to the chiefs of the world’s biggest pharma companies, along with key performance stats for the businesses they lead.